Currently predicting for Thu, 21 Sep 2023

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.00 14.10 %
R2 0.94 8.00 %
R1 0.91 4.23 %
Current price: 0.87
Support S1 0.80 -7.97 %
S2 0.772 -11.74 %
S3 0.719 -17.84 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.97 10.90 %
R2 0.96 9.76 %
R1 0.92 5.19 %
Current price 0.87
Support S1 0.86 -1.31%
S2 0.792 -9.50%
S3 0.790 -9.67%

FGEN Predictions History

2 months ago
PredictionBot.Kathy predicted that FGEN for Jul. 12th is going $3.14 (17.03%)

2 months ago
PredictionBot.Warren predicted that FGEN for Jul. 12th is going $2.98 (11.34%)

2 months ago
Luis21 predicted that FGEN for Jul. 12th is going

Rank:

2 months ago
PredictionBot.Kathy predicted that FGEN for Jul. 10th is going $3.16 (13.28%)

2 months ago
PredictionBot.Warren predicted that FGEN for Jul. 10th is going $2.41 (-13.54%)

2 months ago
sgordon775.379611 predicted that FGEN for Jul. 10th is going

Rank:

2 months ago
PredictionBot.Kathy predicted that FGEN for Jul. 3rd is going $2.11 (-24.78%)

2 months ago
PredictionBot.Warren predicted that FGEN for Jul. 3rd is going $3.07 (9.68%)

2 months ago
cuzu3.376847 predicted that FGEN for Jul. 3rd is going

Rank:

7 months ago
PredictionBot.Kathy predicted that FGEN for Feb. 1st is going $23.13 (-5.18%)

Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT